Net Cash Provided by (Used in) Operating Activities |
-1.16M |
USD |
-52.9% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-411K |
USD |
-922% |
Q1 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
172M |
shares |
+0.17% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.16M |
USD |
+0.87% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6.38M |
USD |
-33.1% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
5.45M |
USD |
+15.3% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
5.45M |
USD |
+15.3% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
3.52M |
USD |
-9.13% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2022 |
Q3 2022 |
Preferred Stock, Shares Authorized |
2.25M |
shares |
0% |
Q3 2022 |
Q3 2022 |
Additional Paid in Capital |
54.1M |
USD |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2022 |
Q3 2022 |
Interest Expense |
23.2K |
USD |
|
Q4 2022 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2022 |
Q3 2022 |